Advanced device invented at ORPE Technologiya for malignant tumors treatment and diagnostics using radiation therapy

25 March 2021
ORPE Technologiya in cooperation with National Medical Research Radiological Center developed a brachytherapy assist device improving the efficiency of malignant tumors diagnostics and treatment using radiation therapy. The device was manufactured involving additive technologies, and at the moment it outperforms its analogues presented in the medical equipment market.   

The device provides more precise positioning of brachytherapy needles used for punctual implantation of radioactive microsources into the tumors or tissues surrounding it. Due to 3D printing application, the device includes 25 positioning channels per 1 square centimeter, which is up 25 per cent from its foreign analogues, and this improves implantation accuracy as well as treatment efficiency.   

 “The development was carried out by ORPE Technologiya in cooperation with National Medical Research Radiological Center. The device application significantly improves the accuracy of brachytherapy needles positioning as well as efficiency of hard-to-find malignant tumors surgeries. The new device is made of cobalt-chromium alloy and, unlike its analogues made of plastic and oxidizable metals, is reusable,” said Oleg Yevtushenko, Executive Director of Rostec. 

The device is designed for brachytherapy of pelvis malignant tumors. There are plans to develop the analogous means intended for treatment of other localization tumors.

“The invention represents the result of the joint work of the two Obninsk research centers. And this is not the first case of effective cooperation of our Enterprise with National Medical Research Radiological Center. Last year, for the medical center we manufactured cabinets intended for protection of physicians from infectious hazards occurring during diagnostic, therapeutic and curative actions. There are also other joint works. This suggests that our technologies can be successfully introduced into the medical industry,” noted Andrei Silkin, Director General of ORPE Technologiya.